Funding

Lighthouse Pharmaceuticals

United States · Biotech · Healthtech

Develops novel small-molecule therapies for neurodegenerative and inflammatory diseases

Visit lighthousepharma.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$12MDouble Point Ventures — Role not disclosed

Investors

Double Point VenturesSeries A

Coverage

Apr 28, 2026Lighthouse Pharmaceuticals · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourceslighthousepharma.com ↗